Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242015049 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Matteo Zurlo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences and Biotechnology, Ferrara University, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: beta-Thalassemia. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, AIFA, UE THALAMOSS Project.
Abstract (Originalsprache)
The β-thalassemias are hereditary monogenic diseases characterized by a low or absent production of adult hemoglobin and excess in the content of α-globin. This excess is cytotoxic for the erythroid cells and responsible for the β-thalassemia-associated ineffective erythropoiesis. Therefore, the decrease in excess α-globin is a relevant clinical effect for these patients and can be realized through the induction of fetal hemoglobin, autophagy, or both. The in vivo effects of sirolimus (rapamycin) and analogs on the induction of fetal hemoglobin (HbF) are of key importance for therapeutic protocols in a variety of hemoglobinopathies, including β-thalassemias. In this research communication, we report data showing that a decrease in autophagy-associated p62 protein, increased expression of ULK-1, and reduction in excess α-globin are occurring in erythroid precursors (ErPCs) stimulated in vitro with low dosages of sirolimus. In addition, increased ULK-1 mRNA content and a decrease in α-globin content were found in ErPCs isolated from β-thalassemia patients recruited for the NCT03877809 clinical trial and treated with 0.5–2 mg/day sirolimus. Our data support the concept that autophagy, ULK1 expression, and α-globin chain reduction should be considered important endpoints in sirolimus-based clinical trials for β-thalassemias.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Life Sciences and Biotechnology, Ferrara University, 44121 Ferrara, Italy.
- Center "Chiara Gemmo and Elio Zago" for the Research on Thalassemia, Ferrara University, 44121 Ferrara, Italy.
- Thalassemia Unit, Arcispedale S. Anna, 44121 Ferrara, Italy.
- Rare Partners S.r.L. Impresa Sociale, 20123 Milano, Italy.
ORCID-Profile: Matteo Zurlo, Marco Prosdocimi, Alessia Finotti, Roberto Gambari
Förderung
- Wellcome Trust
- AIFA
- UE THALAMOSS Project
- University of Ferrara
- Interuniversity Consortium for the Biotechnology (CIB), Italy
Zitieren
APA
Zurlo, M., Zuccato, C., Cosenza, L. C., Gasparello, J., Gamberini, M. R., Stievano, A., Fortini, M., Prosdocimi, M., Finotti, A., & Gambari, R. (2023). Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242015049
Vancouver
Zurlo M, Zuccato C, Cosenza LC, Gasparello J, Gamberini MR, Stievano A, et al. Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242015049
BibTeX
@article{Zurlo2023,
author = {Zurlo, Matteo and Zuccato, Cristina and Cosenza, Lucia Carmela and Gasparello, Jessica and Gamberini, Maria Rita and Stievano, Alice and Fortini, Monica and Prosdocimi, Marco and Finotti, Alessia and Gambari, Roberto},
title = {Decrease in α-Globin and Increase in the Autophagy-Activating Kinase ULK1 mRNA in Erythroid Precursors from β-Thalassemia Patients Treated with Sirolimus},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242015049}
}
EUVIMED